121 related articles for article (PubMed ID: 6218661)
21. Improved renal allograft survival following donor-specific transfusions. III. Kinetics of mixed lymphocyte culture responses before and after transplantation.
Burlingham WJ; Grailer A; Sondel PM; Sollinger HW
Transplantation; 1988 Jan; 45(1):127-32. PubMed ID: 2962347
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.
Alexander JW; Light JA; Donaldson LA; Delmonico FL; Diethelm AG; Wilkinson A; Rosenthal JT; Thistlethwaite JR; Hunsicker LG; Matas AJ; First MR; Reinsmoen NL; Rose SM
Transplantation; 1999 Oct; 68(8):1117-24. PubMed ID: 10551639
[TBL] [Abstract][Full Text] [Related]
23. Effect of six weekly transfusions on canine marrow grafts: tests for sensitization and abrogation of sensitization by procarbazine and antithymocyte serum.
Weiden PL; Storb R; Slichter S; Warren RP; Sale GE
J Immunol; 1976 Jul; 117(1):143-50. PubMed ID: 6593
[TBL] [Abstract][Full Text] [Related]
24. Stability of antigens on leukocytes in banked platelet concentrates: decline in HLA-DR antigen expression and mixed lymphocyte culture stimulating capacity following storage.
Sherman ME; Dzik WH
Blood; 1988 Sep; 72(3):867-72. PubMed ID: 2970874
[TBL] [Abstract][Full Text] [Related]
25. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
[TBL] [Abstract][Full Text] [Related]
26. Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusions.
Flechner SM; Kerman RH; Van Buren C; Kahan BD
Transplantation; 1984 Jan; 37(1):73-6. PubMed ID: 6229913
[TBL] [Abstract][Full Text] [Related]
27. Mixed leucocyte culture, pre- transplant transfusions and renal allograft rejection.
Shons AR; Etheredge EE; Callender CO; Schmidtke JR; Simmons RL; Najarian JS
Proc Eur Dial Transplant Assoc; 1973; 10(0):464-70. PubMed ID: 4278196
[No Abstract] [Full Text] [Related]
28. HLA-DR2, a marker for class I antigen sensitization.
Kreisler JM; Rementeria MC; de Pablo R; Moreno ME
Transplantation; 1988 Jun; 45(6):1071-4. PubMed ID: 3289149
[TBL] [Abstract][Full Text] [Related]
29. Hyperacute rejection in porcine liver transplantation. I. Clinical characteristics, histopathology, and disappearance of donor-specific lymphocytotoxic antibody from serum.
Merion RM; Colletti LM
Transplantation; 1990 May; 49(5):861-8. PubMed ID: 2139985
[TBL] [Abstract][Full Text] [Related]
30. Suppressed antidonor MLC responses in renal transplant candidates conditioned with donor-specific transfusions that carry the recipient's noninherited maternal HLA haplotype.
Bean MA; Mickelson E; Yanagida J; Ishioka S; Brannen GE; Hansen JA
Transplantation; 1990 Feb; 49(2):382-6. PubMed ID: 2137655
[TBL] [Abstract][Full Text] [Related]
31. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
32. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
[TBL] [Abstract][Full Text] [Related]
33. Comparison of immune responsiveness in mice after single or multiple donor-specific transfusions.
Wood ML; Gottschalk R; Monaco AP
J Immunol; 1984 Feb; 132(2):651-5. PubMed ID: 6197472
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of antimonocyte antibody in kidney transplant recipients.
Cerilli GJ; Brasile L; Galouzis T; DeFrancis ME
Transplantation; 1981 Dec; 32(6):495-7. PubMed ID: 6461953
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the allograft response by donor specific blood transfusion: association with reduced local TH1 cytokines and nitric oxide but enhanced prostaglandin E2 production.
Koga S; Luke PP; Specht SM; Rominski B; Jaquins-Gerstl A; Hoffman RA; Thomson AW; Jordan ML
Transplantation; 2000 Dec; 70(12):1788-96. PubMed ID: 11152112
[TBL] [Abstract][Full Text] [Related]
36. [The effect of sensitization to HLA-alloantigens in recipients on the fate of cadaveric renal transplantation].
Lazić M; Petronić V; Marković V; Krasojević-Kostić I; Buturović J; Vucović D
Srp Arh Celok Lek; 1986 Feb; 114(2):161-6. PubMed ID: 3523785
[No Abstract] [Full Text] [Related]
37. Improved allograft survival in nonidentical living related donor transplants using donor-specific blood transfusions.
Mendez R; Mendez RG; Iwaki YI; Kinukawa T; Bogaard TP; Self BA; Terasaki PI
J Urol; 1985 Mar; 133(3):383-5. PubMed ID: 3973987
[TBL] [Abstract][Full Text] [Related]
38. Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients.
Eikmans M; Waanders MM; Roelen DL; van Miert PP; Anholts JD; de Fijter HW; Brand A; Claas FH
Transplantation; 2010 Dec; 90(11):1192-9. PubMed ID: 21166103
[TBL] [Abstract][Full Text] [Related]
39. Effect of pretransplant stored donor-specific blood transfusions on early renal allograft survival in one-haplotype living related transplants.
Whelchel JD; Shaw JF; Curtis JJ; Luke RG; Diethelm AG
Transplantation; 1982 Dec; 34(6):326-9. PubMed ID: 6760491
[TBL] [Abstract][Full Text] [Related]
40. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach.
Salvatierra O; Vincenti F; Amend W; Potter D; Iwaki Y; Opelz G; Terasaki P; Duca R; Cochrum K; Hanes D; Stoney RJ; Feduska NJ
Ann Surg; 1980; 192(4):543-52. PubMed ID: 6448588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
